Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aetna’s Stake In Medicare Part D Will Quadruple With Coventry Acquisition

Executive Summary

Aetna’s acquisition of Coventry Health Care will bring the health insurer’s Part D prescription drug plan membership to 2 million and its Medicaid managed care membership to 2 million.

You may also be interested in...



Aetna/Humana Merger Would Create Fourth-Largest PBM

Strategic refocusing of the in-house PBM likely won't come until after contract with CVS expires in 2019, however.

Aetna/Coventry $15B Pharmacy Spend Will Be Managed By Different PBMs Near Term

Following Aetna’s acquisition of Coventry Health Care, Express Scripts will handle pharmacy benefits for Coventry’s Medicare business through 2015 and its commercial insurance business through 2016, while Aetna has a long-term agreement with CVS Caremark through 2023.

Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds

New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel